• Mashup Score: 1
    myelocast - 8 month(s) ago

    A new Flutter project.

    Tweet Tweets with this article
    • RT @rexprem: If you want to estimate risk of progression in #myeloma, #SMM and #MGUS. Please visit https://t.co/gdgK0qwI2Q. Amazing work by…

  • Mashup Score: 0

    This cohort study analyzes a nationally representative sample with a screening test for monoclonal gammopathy of undetermined significance (MGUS) to evaluate overall survival of populations with MGUS compared with those without MGUS among the general population in the US.

    Tweet Tweets with this article
    • Cohort study shows pts w/monoclonal gammopathy of unclear significance (#MGUS) have 20% higher risk of all-cause mortality than gen US pop'n w/o MGUS, suggesting health implications of MGUS beyond that directly from malignant transformation to #myeloma. https://t.co/YSkzzN94Ef

  • Mashup Score: 22

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • w/@VincentRK, we 🗣 risk stratification + monitoring for #MGUS and to treat or not to treat #SmolderingMyeloma Full discussion: - https://t.co/rElTNWqVAQ - Also on the “Oncology Brothers” podcast 🎙️ #MedEd #HemeTwitter @HemOncFellows #MedTwitter #MMsm @mydocwire #Myeloma https://t.co/7sB8WYQ7E2

  • Mashup Score: 0

    We are preparing a warm welcome in Madrid for the 2023 Intercepting Blood Cancers Meeting (IBC 2023). Taking place from 3-5 March 2023, the IBC 2023 Hybrid Meeting will provide a unique, interactive platform for presentations on key clinical trial data and expert clinical insights for early interventions in blood cancers and how this impacts outcomes for patients; three key topic tracks will…

    Tweet Tweets with this article
    • We’re helping launch the inaugural Intercepting Blood Cancers Workshop (#IBC2023) which is fast approaching🩸📣 Find out more & check out the agenda for the multiple #myeloma/#MGUS/#SMM sessions 👉 https://t.co/URJjMu3tHs Chairs: @IreneGhobrial & Jesús San-Miguel https://t.co/KHKGdT93uE

  • Mashup Score: 0

    AbstractBackground:. Both multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance (MGUS), occur twice as often within Black compared with White populations, suggesting that racial disparities lie within the development of MGUS. Nonetheless, MGUS has been studied mainly in White cohorts; the study that first described the natural history of MGUS was conducted in…

    Tweet Tweets with this article
    • Myeloma precursor monoclonal gammopathy of undetermined significance (#MGUS) is substantially higher in Black South African men than in White populations. This might be associated with potentially modifiable risk factors, e.g., HIV status and smoking. https://t.co/rjMjlDjnUF https://t.co/RNQFFz6l9N

  • Mashup Score: 0

    AbstractBackground:. Both multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance (MGUS), occur twice as often within Black compared with White populations, suggesting that racial disparities lie within the development of MGUS. Nonetheless, MGUS has been studied mainly in White cohorts; the study that first described the natural history of MGUS was conducted in…

    Tweet Tweets with this article
    • Myeloma precursor monoclonal gammopathy of undetermined significance (#MGUS) is substantially higher in Black South African men than in White populations. This might be associated with potentially modifiable risk factors, e.g., HIV status and smoking. https://t.co/so1pVdxvBg https://t.co/2jlO0p0LL9

  • Mashup Score: 2

    Oral and Poster Abstracts Oral 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Disease Monitoring Plasma Cell Disorders, Diseases, Lymphoid Malignancies Robert Palmason1,2,3*, Oscar Berlanga, PhD4*, Jon Kristinn Sigurdsson1*, Sæmundur Rögnvaldsson, MD5,6*, Sigrun Thorsteinsdottir, MD, PhD1,7, Sara Ekberg, PhD8*, Michael Crowther, PhD8*, Marina…

    Tweet Tweets with this article
    • More data from @iStopMM ✅9.8% of MGUS had transient M protein by SPEP/IFE ✅Transient cohort had increased prevalend infections,autoimmune, cancer & COPD ✅When using mass spec only 2.6% were transient #ASH22 #mmsm #MGUS @sykristinsson https://t.co/HJWEheO9Wl https://t.co/60xBWq68Cl